Low-Dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up Report is a research paper published in Diabetes (2021). On theSindex it has a DataRank of 0.824. It has been cited 24 times, with 20 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.483
From this paper's citation signal
Citation Network Contribution
0.341
From 18 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 20 citers.
Leona M. and Harry B. Helmsley Charitable Trust
Grant: 09PG-T1D022
National Institutes of Health National Institute of Allergy and Infectious Diseases
Grant: P01-AI042288
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: T32 DK108736
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: 1UL1TR000064
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: UL1TR000004
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: UL1TR001082
NCATS NIH HHS
Grant: UL1 TR000064
NHGRI NIH HHS
Grant: T32 HG000040
NIAID NIH HHS
Grant: P01 AI042288
McJunkin Family Charitable Foundation
Sanofi-Genzyme
Amgen, Inc.
MeSH Terms